Common Names: snowdrop
This study challenges the previous claim that the snowdrop plant is the Homeric moly mentioned in the Odyssey. Instead, the researchers propose that there is an unidentified group of Mediterranean plants with similar properties. The sea daffodil may have influenced the mythical portrayal of moly.
Plant lectins could be used to combat COVID-19 pandemics by masking the non-glycosylated receptor binding domain of the virus and the corresponding region of the receptor. The ability of plant lectins to interact with the N- and O-glycans present on the spike proteins and their receptors have been analyzed, as well as the in vitro and in vivo anti-COVID-19 activity reported for them. Possible ways for delivery of lectins to block the spikes and/or their receptors are also discussed.
Researchers investigated the effectiveness of plant lectin Galanthus nivalis for binding to the SARS-CoV-2 virus and its variants to develop therapies for severe COVID-19 cases. They tested seven clinically relevant variants and found that viral capture efficiency ranged from 53% to 89%. The study indicated that the use of Galanthus nivalis can be effective and practical in treating severe COVID-19 patients.
Two critically ill COVID-19 patients were treated with a Hemopurifier, which removes mannosylated viruses and exosomes released by activated cells. Both patients tolerated the treatment well. In one patient, removal of exosomes was associated with improved coagulopathy, oxygenation, and clinical recovery. In the second patient, removal of COVID-19 by the Hemopurifier was observed. The Hemopurifier is currently being further investigated in a safety and feasibility study with up to 40 patients in ICU with COVID-19 infection.
Scientists screened 16 compounds for their antiviral activity against feline coronavirus (FCoV), which causes the fatal disease Feline Infectious Peritonitis (FIP) in cats. They found that Galanthus nivalis agglutinin (GNA) and nelfinavir inhibited FCoV replication. However, when the viral load was increased to mimic FIP, the inhibitors lost their effect. When GNA and nelfinavir were combined, they completely blocked viral replication. This suggests that the combined use of GNA and nelfinavir has therapeutic potential in treating cats with early-diagnosed FIP. These findings are important for developing effective treatments and vaccines against FIP.